Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress

alexandrossfakianakis shared this article with you from Inoreader Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress via International Journal of Oral Science - Issue International Journal of Oral Science, Published online: 01 August 2022; doi:10.1038/s41368-022-00193-1 Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.